Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis

American Journal of Cardiology

Volumn 84, Issue 8, 1999, Pages 909-913

  Dellgren, Göran ^a   Eriksson, Maria J ^b   Blange, Irina ^a   Brodin, Lars Åke ^a   Rådegran, Kjell ^b   Sylvén, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

AGED; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 0032864150     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00464-6     Document Type: Article

References (31)

1. Hubert C., Houot A.M., Corvol P., Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem. 266:1991;15377-15383.
2. Soubrier F., Cambien F. Renin-angiotensin system genes as candidate genes in cardiovascular disease. Trends Cardiovasc Med. 3:1993;250-258.
3. Danser A.H.J., Schalekamp M.A.D.H., Bax W.A., van den Brink M.A., Saxena P.R., Riegger G.A.J., Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92:1995;1387-1388.
4. Caulfield M., Newell-Price J. The angiotensin converting enzyme gene in cardiovascular disease. Br Heart J. 74:1995;207-208.
5. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
6. Samani N.J., Thompson J.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 94:1996;708-712.
7. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W.T., Lowes B.D., Zisman L.S., Taft C.S., Perryman B.M. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
8. Marian A.J., Yu Q.T., Workman R., Greve G., Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 342:1993;1085-1086.
9. Lechin M., Quiñones M.A., Omran A., Hill R., Yu Q.T., Rakowski H., Wigle D., Liew C.C., Sole M., Roberts R., Marian A.J. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
10. Schunkert H., Hense H.W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., Riegger G.A.J. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
11. Gharavi A.G., Lipkowitz M.S., Diamond J.A., Jhang J.S., Phillips R.A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol. 77:1996;1315-1319.
12. Andersson B., Sylvén C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 28:1996;162-167.
13. Gunther S., Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 59:1979;679-688.
14. Griffith M.J., Carey C.M., Byrne J.C., Coltart D.J., Jenkins B.S., Webb-Peploe M.M. Echocardiographic left ventricular wall thickness a poor predictor of the severity of aortic valve stenosis . Clin Cardiol. 14:1991;227-231.
15. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
16. Fogarty D.G., Maxwell A.P., Doherty C.C., Hughes A.E., Nevin N.C. ACE gene typing. [letter] Lancet. 343:1994;851.
17. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
18. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
19. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., Silverman N.H., Tajik A.J. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
20. Hatle L., Angelsson B. In Doppler Ultrasound in Cardiology. Physical Principles and Clinical Applications. 2nd ed . 1985;22-26 Lea & Febiger, Philadelphia.
21. Levy D., Savage D.D., Garrisson R.J., Anderson K.M., Kannel W.B., Castelli W.P. Echocardiographic criteria for left ventricular hypertrophy The Framingham Heart Study . Am J Cardiol. 59:1987;956-960.
22. Orsinelli D.A., Aurigemma G.P., Battista S., Krendel S., Gaasch W.H. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. J Am Coll Cardiol. 22:1993;1679-1683.
23. Seiler C., Jenni R. Severe aortic stenosis without left ventricular hypertrophy prevalence, predictors and short-term follow-up after aortic valve replacement . Heart. 76:1996;250-255.
24. Carroll J.D., Carroll E.P., Feldman T., Ward D.M., Lang R.M., McGaughey D., Karp R.B. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 86:1992;1099-1107.
25. Monrad E.S., Hess O.M., Murakami T., Nonogi H., Corin W.J., Krayenbuehl H.P. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 77:1988;1345-1355.
26. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 56:1975;56-64.
27. Lindpaintner K., Le M., Larsson M.G., Rao S., Pfeffer M.A., Ordovas J.M., Schaefer E.J., Wilson A.F., Wilson P.W.F., Vasan R.S., Myers R.H., Levy D. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 334:1996;1023-1028.
28. Griendling K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation. 87:1993;1816-1828.
29. Jin X.Y., Zhang Z.M., Gibson D.G., Yacoub M.H., Pepper J.R. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg. 62:1996;683-690.
30. Frank S., Johnson A., Ross J. Natural history of valvular aortic stenosis. Br Heart J. 35:1973;41-46.
31. Lindblom D. Long-term clinical results after aortic valve replacement with the Björk-Shiley prosthesis. J Thorac Cardiovasc Surg. 95:1988;658-667.